XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.3
UNAUDITED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance, beginning of period at Dec. 31, 2022 $ 560,200 $ 0 $ 165 $ 161,427 $ (6,300) $ 404,908
Balance, beginning of period (in shares) at Dec. 31, 2022     16,564,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 23,163         23,163
Stock issued under compensation plans, net 20   $ 2 18    
Stock issued under compensation plans, net (in shares)     211,000      
Stock-based compensation expense 1,982     1,982    
Shares repurchased related to tax withholding for stock-based compensation (7,936)     (7,194)   (742)
Shares repurchased related to tax withholding for stock-based compensation (in shares)     (76,000)      
Other comprehensive income (loss) 136       136  
Balance, end of period at Mar. 31, 2023 577,565 0 $ 167 156,233 (6,164) 427,329
Balance, end of period (in shares) at Mar. 31, 2023     16,699,000      
Balance, beginning of period at Dec. 31, 2022 560,200 0 $ 165 161,427 (6,300) 404,908
Balance, beginning of period (in shares) at Dec. 31, 2022     16,564,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 66,948          
Shares repurchased related to tax withholding for stock-based compensation (in shares) (76,150)          
Other comprehensive income (loss) $ (335)          
Balance, end of period at Sep. 30, 2023 625,459 0 $ 167 160,813 (6,635) 471,114
Balance, end of period (in shares) at Sep. 30, 2023     16,710,000      
Balance, beginning of period at Mar. 31, 2023 577,565 0 $ 167 156,233 (6,164) 427,329
Balance, beginning of period (in shares) at Mar. 31, 2023     16,699,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 22,273         22,273
Stock issued under compensation plans, net 0          
Stock issued under compensation plans, net (in shares)     11,000      
Stock-based compensation expense 2,322     2,322    
Other comprehensive income (loss) 2,140       2,140  
Balance, end of period at Jun. 30, 2023 604,300 0 $ 167 158,555 (4,024) 449,602
Balance, end of period (in shares) at Jun. 30, 2023     16,710,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 21,512         21,512
Stock-based compensation expense 2,258     2,258    
Other comprehensive income (loss) (2,611)       (2,611)  
Balance, end of period at Sep. 30, 2023 625,459 0 $ 167 160,813 (6,635) 471,114
Balance, end of period (in shares) at Sep. 30, 2023     16,710,000      
Balance, beginning of period at Dec. 31, 2023 651,202 0 $ 167 162,386 (3,880) 492,529
Balance, beginning of period (in shares) at Dec. 31, 2023     16,684,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 18,939         18,939
Stock issued under compensation plans, net 0   $ 1 (1)    
Stock issued under compensation plans, net (in shares)     114,000      
Stock-based compensation expense 1,917     1,917    
Shares repurchased related to tax withholding for stock-based compensation (5,866)   $ (1) (5,511)   (354)
Shares repurchased related to tax withholding for stock-based compensation (in shares)     (36,000)      
Other comprehensive income (loss) (2,472)       (2,472)  
Balance, end of period at Mar. 31, 2024 663,720 0 $ 167 158,791 (6,352) 511,114
Balance, end of period (in shares) at Mar. 31, 2024     16,762,000      
Balance, beginning of period at Dec. 31, 2023 651,202 0 $ 167 162,386 (3,880) 492,529
Balance, beginning of period (in shares) at Dec. 31, 2023     16,684,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income $ 14,311          
Shares repurchased related to tax withholding for stock-based compensation (in shares) (36,397)          
Share repurchases under share repurchase program (in shares) (643,549)          
Other comprehensive income (loss) $ (2,336)          
Balance, end of period at Sep. 30, 2024 588,509 0 $ 161 156,799 (6,216) 437,765
Balance, end of period (in shares) at Sep. 30, 2024     16,122,000      
Balance, beginning of period at Mar. 31, 2024 663,720 0 $ 167 158,791 (6,352) 511,114
Balance, beginning of period (in shares) at Mar. 31, 2024     16,762,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (15,277)         (15,277)
Stock issued under compensation plans, net 0          
Stock issued under compensation plans, net (in shares)     3,000      
Stock-based compensation expense 2,331     2,331    
Share repurchases under share repurchase program (in shares)     (117,000)      
Share repurchases under share repurchase program (16,259)   $ (1) (1,121)   (15,137)
Other comprehensive income (loss) (1,173)       (1,173)  
Balance, end of period at Jun. 30, 2024 633,342 0 $ 166 160,001 (7,525) 480,700
Balance, end of period (in shares) at Jun. 30, 2024     16,648,000      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 10,649         10,649
Stock-based compensation expense 1,950     1,950    
Share repurchases under share repurchase program (in shares)     (526,000)      
Share repurchases under share repurchase program (58,741)   $ (5) (5,152)   (53,584)
Other comprehensive income (loss) 1,309       1,309  
Balance, end of period at Sep. 30, 2024 $ 588,509 $ 0 $ 161 $ 156,799 $ (6,216) $ 437,765
Balance, end of period (in shares) at Sep. 30, 2024     16,122,000